Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-Course Glucocorticoids and Rituximab in ANCA-Associated Vasculitis
NCT02169219Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jun 2014
- Primary completion
- Aug 2016
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisone, rituximab in granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), sponsored by Massachusetts General Hospital. Started Jun 2014; status: completed.
02
Drugs
prednisonerituximab
03
Conditions
granulomatosis with polyangiitis (GPA)microscopic polyangiitis (MPA)
Beyond the preview
Go deeper on NCT02169219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02169219.